Skin Rash – Friday Pop Quiz 1/6/23
An 8-month-old boy is brought in by his mother for concerns of a rash that comes and goes for the last few months, primarily on his face and belly. His older brother suffers from asthma and often has a similar rash on the inside of his elbow and behind his knees.
The gene most commonly mutated in the photograph is also mutated in which of the following?
A.) Palmoplantar keratoderma
B.)� …
An 8-month-old boy is brought in by his mother for concerns of a rash that comes and goes for the last few months, primarily on his face and belly. His older brother suffers from asthma and often has a similar rash on the inside of his elbow and behind his knees.
The gene most commonly mutated in the photograph is also mutated in which of the following?
A.) Palmoplantar keratoderma
B.)� … 
Upadacitinib (RINVOQ®) is a once daily oral medication that is FDA approved for a variety of conditions including psoriatic arthritis and atopic dermatitis. Jak inhibitors, like upadacitinib, are a class of drugs showing to be effective in treating inflammatory conditions. Upadacitnib is not only being used to treat rheumatoid arthritis and psoriatic arthritis, but was recently FDA approved i … 
Atopic dermatitis (AD) is a chronic skin condition characterized by pruritus, inflammation, and acute flare-ups of eczematous lesions over dry skin.1 The wide range of clinical manifestations, the visible nature of the disease, and the intense itching significantly affects patients’ quality of life.2 Up to 80% of children with AD experience sleep disturbances.3 Sixty-seven percent of children … 
Oatmeal has been used as a skin care ingredient since 2000 BC in ancient Egypt, where whole oats were used in soothing baths. Colloidal oat has been the subject of dedicated skin care research starting in the 1950s. After > 30 clinical studies comprised of over 3000 patients including conditions associated with a compromised skin barrier, colloidal oat is now recognized as a skin protectant by … 
During the recent DERM2O22 NP/PA CME conference held July 28-31, 2022, Drs. David Cohen, Brad Glick, and Adam Friedman led a case-based panel discussion on atopic dermatitis (AD) treatment initiation and monitoring. This article provides a summary of their discussion and recommendations.
CASE 1
51-year-old male with a 20-year history of AD. The patient was first seen in September 2015 with BSA … 